The RpoB H₄₈₁Y rifampicin resistance mutation and an active stringent response reduce virulence and increase resistance to innate immune responses in Staphylococcus aureus.
about
Mechanisms of vancomycin resistance in Staphylococcus aureusMolecular Events for Promotion of Vancomycin Resistance in Vancomycin Intermediate Staphylococcus aureusDissecting vancomycin-intermediate resistance in staphylococcus aureus using genome-wide association.Convergent adaptation in the dominant global hospital clone ST239 of methicillin-resistant Staphylococcus aureus.Using a Label Free Quantitative Proteomics Approach to Identify Changes in Protein Abundance in Multidrug-Resistant Mycobacterium tuberculosis.ppGpp negatively impacts ribosome assembly affecting growth and antimicrobial tolerance in Gram-positive bacteriaRifampin Resistance rpoB Alleles or Multicopy Thioredoxin/Thioredoxin Reductase Suppresses the Lethality of Disruption of the Global Stress Regulator spx in Staphylococcus aureusInsights on virulence from the complete genome of Staphylococcus capitis.Stepwise decrease in daptomycin susceptibility in clinical Staphylococcus aureus isolates associated with an initial mutation in rpoB and a compensatory inactivation of the clpX gene.Fitness Cost of Rifampin Resistance in Neisseria meningitidis: In Vitro Study of Mechanisms Associated with rpoB H553Y Mutation.Novel Mutation Sites in the Development of Vancomycin- Intermediate Resistance in Staphylococcus aureus.Adaptive change inferred from genomic population analysis of the ST93 epidemic clone of community-associated methicillin-resistant Staphylococcus aureus.Large tandem chromosome expansions facilitate niche adaptation during persistent infection with drug-resistant Staphylococcus aureusGenome sequence comparisons of serial multi-drug-resistant Mycobacterium tuberculosis isolates over 21 years of infection in a single patientVancomycin in the treatment of methicillin-resistant Staphylococcus aureus - a clinician's guide to the science informing current practice.Functional analysis of the first complete genome sequence of a multidrug resistant sequence type 2 Staphylococcus epidermidis.Interplay Between Antibiotic Resistance and Virulence During Disease Promoted by Multidrug-Resistant Bacteria.Use of bacterial whole-genome sequencing to understand and improve the management of invasive Staphylococcus aureus infections.Prevalence of Slow-growth Vancomycin Non-susceptibility In Methicillin-resistant Staphylococcus aureus.Persistent Staphylococcus aureus isolates from two independent cases of bacteremia display increased bacterial fitness and novel immune evasion phenotypes.A mutation of RNA polymerase β' subunit (RpoC) converts heterogeneously vancomycin-intermediate Staphylococcus aureus (hVISA) into "slow VISA"Cross-talk between two nucleotide-signaling pathways in Staphylococcus aureusTesting the role of genetic background in parallel evolution using the comparative experimental evolution of antibiotic resistance.VraR Binding to the Promoter Region of agr Inhibits Its Function in Vancomycin-Intermediate Staphylococcus aureus (VISA) and Heterogeneous VISA.Convergent Evolution Driven by Rifampin Exacerbates the Global Burden of Drug-Resistant Staphylococcus aureus.WalK(S221P), a naturally occurring mutation, confers vancomycin resistance in VISA strain XN108.Altered Mycobacterium tuberculosis Cell Wall Metabolism and Physiology Associated With RpoB Mutation H526D.Epistasis between antibiotic resistance mutations and genetic background shape the fitness effect of resistance across species of Pseudomonas.Microarray based transcriptome profile data of ∆ and ∆ strains of
P2860
Q26829312-CDC1E37B-E2AC-4F04-99BE-6B41B1F0B600Q28078930-8374D7C8-72A2-43E7-9785-04EB4EDCCE79Q33696380-B2EDE63D-65F3-4EF8-8F0B-B28C106E6EE7Q35172374-E467D425-BCEC-4076-952D-7D7E34A727C9Q35186976-19E35978-8B45-4F7B-8C3C-CA3C146F7571Q35948392-1EC1ACEF-56FB-47AF-8436-361B5C90D6BDQ36081351-9D93CF35-D8E7-42C3-B540-AE83A3E10EE2Q36098105-B9F9BE87-7071-4608-B2A7-62D194384FD2Q36158472-A4C9A183-54E8-40B4-BCCD-FCAB53B00396Q36290567-C572C54D-EE9A-4510-81A0-C8B9BFA2F0FCQ37575024-771842CA-A852-47EC-BA96-D7AB49F6E3C5Q37616524-C3F9718E-A9AA-4041-9375-C97B1A152E66Q37658042-49CF57E7-657F-48A4-9EF6-7BE0F1B0315AQ37658279-78AE138D-B033-474A-8A46-DFBE528AEE5BQ38462842-28C4A3CB-82F6-49A7-BB21-167F2105FD00Q38645718-42D1775F-19F7-40BC-B6E7-09CFF81279FAQ39218893-A12588BD-934D-42A7-8F3B-2050DD5BD275Q39392178-6B49DD03-DF9A-4A69-AF4F-0F9B1F048983Q40085144-92415609-47AC-41D3-8E69-EC3A951F235FQ40855979-0A047545-23D2-4AF6-B09C-41084D480759Q41259277-5850D632-C68E-43F2-8EF8-C4F78D4DE1AEQ41552640-3F63D2CF-BB9D-421E-AC9E-C9297EECBE89Q41846993-E7BBFB8C-C236-415F-A9B9-69ABFBCA73B2Q42358800-C2E50697-9D5E-4C79-A094-1DCA3DE28917Q48505745-622AB1AB-8B9F-4436-B825-84CFA6431205Q51247058-1E3BDCD0-7B14-4700-B614-29AD53DEDDE6Q53698585-CB1E11B5-E5CA-4719-9674-4C4D48761260Q53780871-BE336A31-CE77-40AC-8448-73D2B2697415Q58123177-0CE91D24-D45A-4A37-9E6A-10617053826B
P2860
The RpoB H₄₈₁Y rifampicin resistance mutation and an active stringent response reduce virulence and increase resistance to innate immune responses in Staphylococcus aureus.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
The RpoB H₄₈₁Y rifampicin resi ...... nses in Staphylococcus aureus.
@en
type
label
The RpoB H₄₈₁Y rifampicin resi ...... nses in Staphylococcus aureus.
@en
prefLabel
The RpoB H₄₈₁Y rifampicin resi ...... nses in Staphylococcus aureus.
@en
P2093
P2860
P50
P356
P1476
The RpoB H₄₈₁Y rifampicin resi ...... nses in Staphylococcus aureus.
@en
P2093
David R Cameron
John K Davies
Justin Stepnell
Michael R Yeaman
P2860
P304
P356
10.1093/INFDIS/JIS772
P407
P577
2012-12-18T00:00:00Z